Global Biologics Drug Discovery Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 278209
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Biologics Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Biologics Drug Discovery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Biologics Drug Discovery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biologicals segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Biologics Drug Discovery include GenScript, Roche, Pfizer, Novartis, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Biologics Drug Discovery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Biologicals

Monoclonal Antibodies

Recombinant Proteins

Other Biologics

Market segment by Application, can be divided into

Hospitals

Clinics

Research Labs

Diagnostic Centers

Others

Market segment by players, this report covers

GenScript

Roche

Pfizer

Novartis

Sanofi

Merck

GlaxoSmithKline

AstraZeneca

AbbVie

Amgen

Bristol-Myers Squibb

Novo Nordisk

Allergan

Astellas Pharma

Teva Pharmaceutical Industries

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Biologics Drug Discovery product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biologics Drug Discovery, with revenue, gross margin and global market share of Biologics Drug Discovery from 2019 to 2022.

Chapter 3, the Biologics Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologics Drug Discovery market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Biologics Drug Discovery research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Biologics Drug Discovery

1.2 Classification of Biologics Drug Discovery by Type

1.2.1 Overview: Global Biologics Drug Discovery Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Biologics Drug Discovery Revenue Market Share by Type in 2021

1.2.3 Biologicals

1.2.4 Monoclonal Antibodies

1.2.5 Recombinant Proteins

1.2.6 Other Biologics

1.3 Global Biologics Drug Discovery Market by Application

1.3.1 Overview: Global Biologics Drug Discovery Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Labs

1.3.5 Diagnostic Centers

1.3.6 Others

1.4 Global Biologics Drug Discovery Market Size & Forecast

1.5 Global Biologics Drug Discovery Market Size and Forecast by Region

1.5.1 Global Biologics Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Biologics Drug Discovery Market Size by Region, (2017-2022)

1.5.3 North America Biologics Drug Discovery Market Size and Prospect (2017-2028)

1.5.4 Europe Biologics Drug Discovery Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Biologics Drug Discovery Market Size and Prospect (2017-2028)

1.5.6 South America Biologics Drug Discovery Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Biologics Drug Discovery Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Biologics Drug Discovery Market Drivers

1.6.2 Biologics Drug Discovery Market Restraints

1.6.3 Biologics Drug Discovery Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 GenScript

2.1.1 GenScript Details

2.1.2 GenScript Major Business

2.1.3 GenScript Biologics Drug Discovery Product and Solutions

2.1.4 GenScript Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 GenScript Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche Biologics Drug Discovery Product and Solutions

2.2.4 Roche Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Roche Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Biologics Drug Discovery Product and Solutions

2.3.4 Pfizer Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Biologics Drug Discovery Product and Solutions

2.4.4 Novartis Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Biologics Drug Discovery Product and Solutions

2.5.4 Sanofi Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Merck

2.6.1 Merck Details

2.6.2 Merck Major Business

2.6.3 Merck Biologics Drug Discovery Product and Solutions

2.6.4 Merck Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Merck Recent Developments and Future Plans

2.7 GlaxoSmithKline

2.7.1 GlaxoSmithKline Details

2.7.2 GlaxoSmithKline Major Business

2.7.3 GlaxoSmithKline Biologics Drug Discovery Product and Solutions

2.7.4 GlaxoSmithKline Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 GlaxoSmithKline Recent Developments and Future Plans

2.8 AstraZeneca

2.8.1 AstraZeneca Details

2.8.2 AstraZeneca Major Business

2.8.3 AstraZeneca Biologics Drug Discovery Product and Solutions

2.8.4 AstraZeneca Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 AstraZeneca Recent Developments and Future Plans

2.9 AbbVie

2.9.1 AbbVie Details

2.9.2 AbbVie Major Business

2.9.3 AbbVie Biologics Drug Discovery Product and Solutions

2.9.4 AbbVie Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 AbbVie Recent Developments and Future Plans

2.10 Amgen

2.10.1 Amgen Details

2.10.2 Amgen Major Business

2.10.3 Amgen Biologics Drug Discovery Product and Solutions

2.10.4 Amgen Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Amgen Recent Developments and Future Plans

2.11 Bristol-Myers Squibb

2.11.1 Bristol-Myers Squibb Details

2.11.2 Bristol-Myers Squibb Major Business

2.11.3 Bristol-Myers Squibb Biologics Drug Discovery Product and Solutions

2.11.4 Bristol-Myers Squibb Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.12 Novo Nordisk

2.12.1 Novo Nordisk Details

2.12.2 Novo Nordisk Major Business

2.12.3 Novo Nordisk Biologics Drug Discovery Product and Solutions

2.12.4 Novo Nordisk Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Novo Nordisk Recent Developments and Future Plans

2.13 Allergan

2.13.1 Allergan Details

2.13.2 Allergan Major Business

2.13.3 Allergan Biologics Drug Discovery Product and Solutions

2.13.4 Allergan Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Allergan Recent Developments and Future Plans

2.14 Astellas Pharma

2.14.1 Astellas Pharma Details

2.14.2 Astellas Pharma Major Business

2.14.3 Astellas Pharma Biologics Drug Discovery Product and Solutions

2.14.4 Astellas Pharma Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Astellas Pharma Recent Developments and Future Plans

2.15 Teva Pharmaceutical Industries

2.15.1 Teva Pharmaceutical Industries Details

2.15.2 Teva Pharmaceutical Industries Major Business

2.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Product and Solutions

2.15.4 Teva Pharmaceutical Industries Biologics Drug Discovery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Teva Pharmaceutical Industries Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Biologics Drug Discovery Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Biologics Drug Discovery Players Market Share in 2021

3.2.2 Top 10 Biologics Drug Discovery Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Biologics Drug Discovery Players Head Office, Products and Services Provided

3.4 Biologics Drug Discovery Mergers & Acquisitions

3.5 Biologics Drug Discovery New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Biologics Drug Discovery Revenue and Market Share by Type (2017-2022)

4.2 Global Biologics Drug Discovery Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Biologics Drug Discovery Revenue Market Share by Application (2017-2022)

5.2 Global Biologics Drug Discovery Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Biologics Drug Discovery Revenue by Type (2017-2028)

6.2 North America Biologics Drug Discovery Revenue by Application (2017-2028)

6.3 North America Biologics Drug Discovery Market Size by Country

6.3.1 North America Biologics Drug Discovery Revenue by Country (2017-2028)

6.3.2 United States Biologics Drug Discovery Market Size and Forecast (2017-2028)

6.3.3 Canada Biologics Drug Discovery Market Size and Forecast (2017-2028)

6.3.4 Mexico Biologics Drug Discovery Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Biologics Drug Discovery Revenue by Type (2017-2028)

7.2 Europe Biologics Drug Discovery Revenue by Application (2017-2028)

7.3 Europe Biologics Drug Discovery Market Size by Country

7.3.1 Europe Biologics Drug Discovery Revenue by Country (2017-2028)

7.3.2 Germany Biologics Drug Discovery Market Size and Forecast (2017-2028)

7.3.3 France Biologics Drug Discovery Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Biologics Drug Discovery Market Size and Forecast (2017-2028)

7.3.5 Russia Biologics Drug Discovery Market Size and Forecast (2017-2028)

7.3.6 Italy Biologics Drug Discovery Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Biologics Drug Discovery Revenue by Type (2017-2028)

8.2 Asia-Pacific Biologics Drug Discovery Revenue by Application (2017-2028)

8.3 Asia-Pacific Biologics Drug Discovery Market Size by Region

8.3.1 Asia-Pacific Biologics Drug Discovery Revenue by Region (2017-2028)

8.3.2 China Biologics Drug Discovery Market Size and Forecast (2017-2028)

8.3.3 Japan Biologics Drug Discovery Market Size and Forecast (2017-2028)

8.3.4 South Korea Biologics Drug Discovery Market Size and Forecast (2017-2028)

8.3.5 India Biologics Drug Discovery Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Biologics Drug Discovery Market Size and Forecast (2017-2028)

8.3.7 Australia Biologics Drug Discovery Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Biologics Drug Discovery Revenue by Type (2017-2028)

9.2 South America Biologics Drug Discovery Revenue by Application (2017-2028)

9.3 South America Biologics Drug Discovery Market Size by Country

9.3.1 South America Biologics Drug Discovery Revenue by Country (2017-2028)

9.3.2 Brazil Biologics Drug Discovery Market Size and Forecast (2017-2028)

9.3.3 Argentina Biologics Drug Discovery Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Biologics Drug Discovery Revenue by Type (2017-2028)

10.2 Middle East & Africa Biologics Drug Discovery Revenue by Application (2017-2028)

10.3 Middle East & Africa Biologics Drug Discovery Market Size by Country

10.3.1 Middle East & Africa Biologics Drug Discovery Revenue by Country (2017-2028)

10.3.2 Turkey Biologics Drug Discovery Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Biologics Drug Discovery Market Size and Forecast (2017-2028)

10.3.4 UAE Biologics Drug Discovery Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Biologics Drug Discovery Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Biologics Drug Discovery Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Biologics Drug Discovery Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Biologics Drug Discovery Revenue (USD Million) by Region (2017-2022)

Table 5. Global Biologics Drug Discovery Revenue Market Share by Region (2023-2028)

Table 6. GenScript Corporate Information, Head Office, and Major Competitors

Table 7. GenScript Major Business

Table 8. GenScript Biologics Drug Discovery Product and Solutions

Table 9. GenScript Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche Biologics Drug Discovery Product and Solutions

Table 13. Roche Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Biologics Drug Discovery Product and Solutions

Table 17. Pfizer Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Biologics Drug Discovery Product and Solutions

Table 21. Novartis Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Biologics Drug Discovery Product and Solutions

Table 25. Sanofi Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Merck Corporate Information, Head Office, and Major Competitors

Table 27. Merck Major Business

Table 28. Merck Biologics Drug Discovery Product and Solutions

Table 29. Merck Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 31. GlaxoSmithKline Major Business

Table 32. GlaxoSmithKline Biologics Drug Discovery Product and Solutions

Table 33. GlaxoSmithKline Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 35. AstraZeneca Major Business

Table 36. AstraZeneca Biologics Drug Discovery Product and Solutions

Table 37. AstraZeneca Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. AbbVie Corporate Information, Head Office, and Major Competitors

Table 39. AbbVie Major Business

Table 40. AbbVie Biologics Drug Discovery Product and Solutions

Table 41. AbbVie Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Amgen Corporate Information, Head Office, and Major Competitors

Table 43. Amgen Major Business

Table 44. Amgen Biologics Drug Discovery Product and Solutions

Table 45. Amgen Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 47. Bristol-Myers Squibb Major Business

Table 48. Bristol-Myers Squibb Biologics Drug Discovery Product and Solutions

Table 49. Bristol-Myers Squibb Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 51. Novo Nordisk Major Business

Table 52. Novo Nordisk Biologics Drug Discovery Product and Solutions

Table 53. Novo Nordisk Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Allergan Corporate Information, Head Office, and Major Competitors

Table 55. Allergan Major Business

Table 56. Allergan Biologics Drug Discovery Product and Solutions

Table 57. Allergan Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 59. Astellas Pharma Major Business

Table 60. Astellas Pharma Biologics Drug Discovery Product and Solutions

Table 61. Astellas Pharma Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors

Table 63. Teva Pharmaceutical Industries Major Business

Table 64. Teva Pharmaceutical Industries Biologics Drug Discovery Product and Solutions

Table 65. Teva Pharmaceutical Industries Biologics Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Biologics Drug Discovery Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Biologics Drug Discovery Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Biologics Drug Discovery by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Biologics Drug Discovery Players Head Office, Products and Services Provided

Table 70. Biologics Drug Discovery Mergers & Acquisitions in the Past Five Years

Table 71. Biologics Drug Discovery New Entrants and Expansion Plans

Table 72. Global Biologics Drug Discovery Revenue (USD Million) by Type (2017-2022)

Table 73. Global Biologics Drug Discovery Revenue Share by Type (2017-2022)

Table 74. Global Biologics Drug Discovery Revenue Forecast by Type (2023-2028)

Table 75. Global Biologics Drug Discovery Revenue by Application (2017-2022)

Table 76. Global Biologics Drug Discovery Revenue Forecast by Application (2023-2028)

Table 77. North America Biologics Drug Discovery Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Biologics Drug Discovery Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Biologics Drug Discovery Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Biologics Drug Discovery Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Biologics Drug Discovery Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Biologics Drug Discovery Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Biologics Drug Discovery Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Biologics Drug Discovery Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Biologics Drug Discovery Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Biologics Drug Discovery Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Biologics Drug Discovery Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Biologics Drug Discovery Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Biologics Drug Discovery Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Biologics Drug Discovery Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Biologics Drug Discovery Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Biologics Drug Discovery Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Biologics Drug Discovery Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Biologics Drug Discovery Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Biologics Drug Discovery Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Biologics Drug Discovery Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Biologics Drug Discovery Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Biologics Drug Discovery Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Biologics Drug Discovery Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Biologics Drug Discovery Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Biologics Drug Discovery Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Biologics Drug Discovery Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Biologics Drug Discovery Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Biologics Drug Discovery Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Biologics Drug Discovery Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Biologics Drug Discovery Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Biologics Drug Discovery Picture

Figure 2. Global Biologics Drug Discovery Revenue Market Share by Type in 2021

Figure 3. Biologicals

Figure 4. Monoclonal Antibodies

Figure 5. Recombinant Proteins

Figure 6. Other Biologics

Figure 7. Biologics Drug Discovery Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Research Labs Picture

Figure 11. Diagnostic Centers Picture

Figure 12. Others Picture

Figure 13. Global Biologics Drug Discovery Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Biologics Drug Discovery Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Biologics Drug Discovery Revenue Market Share by Region (2017-2028)

Figure 16. Global Biologics Drug Discovery Revenue Market Share by Region in 2021

Figure 17. North America Biologics Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Biologics Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Biologics Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Biologics Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Biologics Drug Discovery Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Biologics Drug Discovery Market Drivers

Figure 23. Biologics Drug Discovery Market Restraints

Figure 24. Biologics Drug Discovery Market Trends

Figure 25. GenScript Recent Developments and Future Plans

Figure 26. Roche Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. Novartis Recent Developments and Future Plans

Figure 29. Sanofi Recent Developments and Future Plans

Figure 30. Merck Recent Developments and Future Plans

Figure 31. GlaxoSmithKline Recent Developments and Future Plans

Figure 32. AstraZeneca Recent Developments and Future Plans

Figure 33. AbbVie Recent Developments and Future Plans

Figure 34. Amgen Recent Developments and Future Plans

Figure 35. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 36. Novo Nordisk Recent Developments and Future Plans

Figure 37. Allergan Recent Developments and Future Plans

Figure 38. Astellas Pharma Recent Developments and Future Plans

Figure 39. Teva Pharmaceutical Industries Recent Developments and Future Plans

Figure 40. Global Biologics Drug Discovery Revenue Share by Players in 2021

Figure 41. Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 42. Global Top 3 Players Biologics Drug Discovery Revenue Market Share in 2021

Figure 43. Global Top 10 Players Biologics Drug Discovery Revenue Market Share in 2021

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 45. Global Biologics Drug Discovery Revenue Share by Type in 2021

Figure 46. Global Biologics Drug Discovery Market Share Forecast by Type (2023-2028)

Figure 47. Global Biologics Drug Discovery Revenue Share by Application in 2021

Figure 48. Global Biologics Drug Discovery Market Share Forecast by Application (2023-2028)

Figure 49. North America Biologics Drug Discovery Sales Market Share by Type (2017-2028)

Figure 50. North America Biologics Drug Discovery Sales Market Share by Application (2017-2028)

Figure 51. North America Biologics Drug Discovery Revenue Market Share by Country (2017-2028)

Figure 52. United States Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Canada Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Mexico Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Europe Biologics Drug Discovery Sales Market Share by Type (2017-2028)

Figure 56. Europe Biologics Drug Discovery Sales Market Share by Application (2017-2028)

Figure 57. Europe Biologics Drug Discovery Revenue Market Share by Country (2017-2028)

Figure 58. Germany Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. France Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. United Kingdom Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Russia Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Italy Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Asia-Pacific Biologics Drug Discovery Sales Market Share by Type (2017-2028)

Figure 64. Asia-Pacific Biologics Drug Discovery Sales Market Share by Application (2017-2028)

Figure 65. Asia-Pacific Biologics Drug Discovery Revenue Market Share by Region (2017-2028)

Figure 66. China Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Japan Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South Korea Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. India Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Southeast Asia Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Australia Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South America Biologics Drug Discovery Sales Market Share by Type (2017-2028)

Figure 73. South America Biologics Drug Discovery Sales Market Share by Application (2017-2028)

Figure 74. South America Biologics Drug Discovery Revenue Market Share by Country (2017-2028)

Figure 75. Brazil Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Argentina Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Middle East and Africa Biologics Drug Discovery Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Biologics Drug Discovery Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Biologics Drug Discovery Revenue Market Share by Country (2017-2028)

Figure 80. Turkey Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Saudi Arabia Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. UAE Biologics Drug Discovery Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source